Naldemedine is a peripherally acting mu-opioid receptor antagonist indicated for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain. As a derivative of naltrexone,… Read more
Naldemedine is a peripherally acting mu-opioid receptor antagonist indicated for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain. As a derivative of naltrexone, it is designed to block the constipating effects of opioids in the gastrointestinal tract without reversing their analgesic effects in the central nervous system. This category of high-quality reference standards includes Naldemedine impurities, major metabolites such as nor-naldemedine and glucuronide conjugates, and stable isotope labelled compounds like Naldemedine-d5. These reference materials are essential for pharmaceutical laboratories engaged in impurity profiling, method validation, and rigorous quality control. Using these compounds, analytical chemists can accurately identify and quantify related substances during stability testing and pharmacokinetic studies to ensure the purity, safety, and regulatory compliance of the active pharmaceutical ingredient.